Autoimmune diseases are typically managed by generalized immunosuppression, including rituximab to deplete B cells, FcRn blockers to lower circulating antibody levels, inhibitors of complement to reduce cell damage, and steroids that broadly suppress immune function. Here, FCGRT is linked to autoimmune disease.